BioPharma’s New Best Friend: BlueGenes and an Interview with IBM’s Chief Architect and Designer James Sexton

June 28, 2007
IBM just introduced its new supercomputer, BlueGene, this week.  It's hard not to be astonished by the new device, which can handle 1,000 billion calculations a second, the equivalent of 100,000 PCs in computing power, or, for those who like graphic descriptions, of a stack of P.C.'s 1.5 miles high. Drug development, especially in biotech, will be the primary beneficiaries of this computer which took five years and $100 million to develop.  Click here to watch Bloomberg's interview with chief architect and designer Jim Sexton. The company plans to roll out a computer with 10 times the power in three to four years. -AMS
IBM just introduced its new supercomputer, BlueGene, this week.  It's hard not to be astonished by the new device, which can handle 1,000 billion calculations a second, the equivalent of 100,000 PCs in computing power, or, for those who like graphic descriptions, of a stack of P.C.'s 1.5 miles high. Drug development, especially in biotech, will be the primary beneficiaries of this computer which took five years and $100 million to develop.  Click here to watch Bloomberg's interview with chief architect and designer Jim Sexton. The company plans to roll out a computer with 10 times the power in three to four years. -AMS
About the Author

pharmamanufacturing | pharmamanufacturing